IN DEPTHCan gene therapies for haemophilia defend their high price tags?Trial termination analysis unveils a silver lining for patient recruitmentNew dawn for the EU's joint procurement crisis responseRegulatoryWhat Rishi Sunak can do for the UK pharma industryAmidst a swap in leadership, the pharmaceutical industry hopes Rishi Sunak will free up funding and boost the economyBig DataInside the European mass shift to data-driven health solutionsMarket AccessDrug shortages signal difficult outlook for cardiovascular careCan gene therapies for haemophilia defend their high price tags?Trial termination analysis unveils a silver lining for patient recruitmentNew dawn for the EU's joint procurement crisis response 02/24/2024 17:02:41
Can gene therapies for haemophilia defend their high price tags?
Trial termination analysis unveils a silver lining for patient recruitment
New dawn for the EU's joint procurement crisis response